Sinopharm Holding Distribution Co., Ltd Sustainability Profile
Sinopharm Holding Distribution Co., Ltd., a prominent player in the pharmaceutical distribution industry, is headquartered in China (CN). Established in 2003, the company has rapidly expanded its operations across major regions, including Asia and the Middle East, solidifying its position as a leader in healthcare logistics. Specialising in the distribution of pharmaceuticals, medical devices, and healthcare products, Sinopharm is renowned for its extensive supply chain network and commitment to quality. The company’s core services include warehousing, transportation, and inventory management, which are tailored to meet the diverse needs of healthcare providers. With a strong market presence, Sinopharm Holding has achieved significant milestones, including partnerships with leading pharmaceutical manufacturers. Its dedication to innovation and efficiency has earned it a reputation for reliability and excellence in the healthcare sector.
DitchCarbon Score
How does Sinopharm Holding Distribution Co., Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sinopharm Holding Distribution Co., Ltd's score of 23 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sinopharm Holding Distribution Co., Ltd, headquartered in China (CN), currently does not report specific carbon emissions data for the most recent year, as indicated by the absence of emissions figures. The company is a current subsidiary of Sinopharm Group Co. Ltd., which may influence its climate commitments and performance metrics. As of now, there are no documented reduction targets or climate pledges from Sinopharm Holding Distribution Co., Ltd. However, emissions data and performance metrics may be inherited from its parent company, Sinopharm Group Co. Ltd., which operates at a cascade level of 1. This means that any climate initiatives or targets set by Sinopharm Group could potentially impact Sinopharm Holding's strategies and commitments. In the absence of specific emissions data and reduction initiatives, it is essential to monitor the broader context of Sinopharm Group's climate actions, as these may inform the subsidiary's future commitments and performance in addressing carbon emissions.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 30,741,540 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 88,611,470 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | 000,000,000 |
How Carbon Intensive is Sinopharm Holding Distribution Co., Ltd's Industry?
How Carbon Intensive is Sinopharm Holding Distribution Co., Ltd's Location?
Sinopharm Holding Distribution Co., Ltd's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Sinopharm Holding Distribution Co., Ltd has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
